Abstract
The head and neck cancer (HNC) is a worldwide public health issue, affecting thousands of people each year, whose mortality rate has remained virtually unchanged in the last decades. In order to seek new and more effective therapeutic approaches against cancer, microRNAs (miRs) have received great attention in view of the ability of these molecules to bind to a hundreds of target transcri…